Fuji Moves Astaxanthin Production Out of Hawaii

January 13, 2011

Fuji Chemical Industry Co. has shifted its commercial cultivation of astaxanthin source Haematococcus pluvialis from its facility in Hawaii to its Swedish facility.

Fuji Chemical Industry Co. has shifted its commercial cultivation of astaxanthin source Haematococcus pluvialis from its facility in Hawaii to its Swedish facility. The company says the decision was made to achieve “better product uniformity, operational efficiency, and ease of expansion.”

Fuji said that although both facilities were fully enclosed bio-systems, each equally producing high levels of astaxanthin, the “two technologies were different [and] consolidating operations into one of the two technologies would avoid duplication of effort and achieve operational efficiency.” It noted that the Swedish facility survived because it can be expanded rapidly.

The company is still considering pursuing algal development at the Hawaii location.